全文获取类型
收费全文 | 31432篇 |
免费 | 2430篇 |
国内免费 | 71篇 |
专业分类
耳鼻咽喉 | 525篇 |
儿科学 | 798篇 |
妇产科学 | 699篇 |
基础医学 | 3319篇 |
口腔科学 | 906篇 |
临床医学 | 3560篇 |
内科学 | 6666篇 |
皮肤病学 | 916篇 |
神经病学 | 2130篇 |
特种医学 | 1461篇 |
外科学 | 5454篇 |
综合类 | 473篇 |
一般理论 | 24篇 |
预防医学 | 2850篇 |
眼科学 | 606篇 |
药学 | 1985篇 |
中国医学 | 24篇 |
肿瘤学 | 1537篇 |
出版年
2021年 | 364篇 |
2020年 | 210篇 |
2019年 | 346篇 |
2018年 | 391篇 |
2017年 | 285篇 |
2016年 | 356篇 |
2015年 | 879篇 |
2014年 | 1080篇 |
2013年 | 1374篇 |
2012年 | 1681篇 |
2011年 | 1622篇 |
2010年 | 1194篇 |
2009年 | 1110篇 |
2008年 | 1592篇 |
2007年 | 1524篇 |
2006年 | 1530篇 |
2005年 | 1480篇 |
2004年 | 1278篇 |
2003年 | 1019篇 |
2002年 | 975篇 |
2001年 | 984篇 |
2000年 | 1010篇 |
1999年 | 868篇 |
1998年 | 321篇 |
1997年 | 297篇 |
1996年 | 275篇 |
1995年 | 275篇 |
1994年 | 224篇 |
1993年 | 233篇 |
1992年 | 623篇 |
1991年 | 649篇 |
1990年 | 599篇 |
1989年 | 534篇 |
1988年 | 502篇 |
1987年 | 491篇 |
1986年 | 488篇 |
1985年 | 478篇 |
1984年 | 351篇 |
1983年 | 321篇 |
1982年 | 244篇 |
1981年 | 232篇 |
1980年 | 177篇 |
1979年 | 345篇 |
1978年 | 243篇 |
1977年 | 211篇 |
1976年 | 174篇 |
1975年 | 174篇 |
1974年 | 220篇 |
1973年 | 211篇 |
1971年 | 196篇 |
排序方式: 共有10000条查询结果,搜索用时 16 毫秒
11.
12.
Auda A. Eltahla Fabio Luciani Peter A. White Andrew R. Lloyd Rowena A. Bull 《Viruses》2015,7(10):5206-5224
The hepatitis C virus (HCV) is a pandemic human pathogen posing a substantial health and economic burden in both developing and developed countries. Controlling the spread of HCV through behavioural prevention strategies has met with limited success and vaccine development remains slow. The development of antiviral therapeutic agents has also been challenging, primarily due to the lack of efficient cell culture and animal models for all HCV genotypes, as well as the large genetic diversity between HCV strains. On the other hand, the use of interferon-α-based treatments in combination with the guanosine analogue, ribavirin, achieved limited success, and widespread use of these therapies has been hampered by prevalent side effects. For more than a decade, the HCV RNA-dependent RNA polymerase (RdRp) has been targeted for antiviral development. Direct acting antivirals (DAA) have been identified which bind to one of at least six RdRp inhibitor-binding sites, and are now becoming a mainstay of highly effective and well tolerated antiviral treatment for HCV infection. Here we review the different classes of RdRp inhibitors and their mode of action against HCV. Furthermore, the mechanism of antiviral resistance to each class is described, including naturally occurring resistance-associated variants (RAVs) in different viral strains and genotypes. Finally, we review the impact of these RAVs on treatment outcomes with the newly developed regimens. 相似文献
13.
14.
15.
Sirt5 is known to functionally regulate mitochondrial proteins by altering posttranslational modifications, including lysine desuccinylation. While roles for Sirt5 as either a tumor promoter or suppressor, or in chemoresistance, have been implicated in other cancers, the function of Sirt5 in cutaneous melanoma has not been well examined. Therefore, to determine whether Sirt5 is necessary for BrafV600E‐mediated melanoma formation and/or disease progression, we crossed a genetically engineered murine melanoma model (TyrCreERT2/+; BrafLSL‐V600E/+; Ptenflox/flox) to Sirt5?/? knockout animals. In addition, we tested for synergism with a selective BRAF (V600E) inhibitor in Sirt5?/? mouse melanoma cells. Taken together, this report demonstrates that, in these models, Sirt5 is dispensable for BrafV600E‐mediated cutaneous melanoma formation and growth in vivo, and does not improve sensitivity to a selective BRAF inhibitor. 相似文献
16.
17.
Phantana-angkool April Voci Amy E. Warren Yancey E. Livasy Chad A. Beasley Lakesha M. Robinson Myra M. Hadzikadic-Gusic Lejla Sarantou Terry Forster Meghan R. Sarma Deba White Richard L. 《Annals of surgical oncology》2019,26(12):3874-3882
Annals of Surgical Oncology - The role of sentinel lymph node biopsy (SLNB) when ductal carcinoma in situ with microinvasion (DCISM) is identified on core biopsy is unclear. Our aim was to assess... 相似文献
18.
Chronic transplant dysfunction is a complex dynamic pathogenic process. Clinically, a decrease in glomerular filtration rate (GFR) becomes apparent leading to chronic renal insufficiency and dialysis or death from cardiovascular events. Chronic transplant dysfunction can develop into a chronic alIograft nephropathy (CAN) as a specific entity with dynamic progression. CAN includes a collection of immunologic and non-immunologic factors, rejection, ischemia time, donor and recipient characteristics and toxicity of calcineurin inhibitors. Despite improvements in immunosuppression, the long-range prognosis of renal allografts has not improved. Whether modern immunosuppressive concepts with reduction or avoidance of calcineurin inhibitors and a therapy based on antimetabolites, such as mycophenolate or mTOR-inhibitors could lead to a prolongation of transplant survival, remains to be seen. 相似文献
19.
20.